Patents
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
01/2008
01/17/2008CA2657719A1 Cyclopentane derivatives as antiglaucoma agents
01/16/2008EP1204626B1 Ether compounds, compositions, and uses thereof
01/16/2008CN101107226A Phenoxyacetic acid derivatives useful for treating respiratory diseases
01/15/2008US7319173 Process for preparing fluorohalogenethers
01/15/2008US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism
01/15/2008US7319161 Reacting butadiene and maleic acid; hydrogenation; plasticizing plastics
01/15/2008US7319096 Antiarrhythmia agents; liver disorders; skin disorders
01/10/2008WO2008005451A2 Optical apparatus and methods for chemical analysis
01/10/2008US20080007840 Optical apparatus and methods for chemical analysis
01/09/2008EP1409449B1 Alpha-ketoglutarates of active ingredients and compositions containing same
01/09/2008CN101102989A Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions
01/09/2008CN101100527A Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents
01/08/2008US7317100 C4-demethyl-epothilones or C4-bisnor-epothilones from reacting 2S,6R,7S,9S)-6,7-Epoxy-9-hydroxy-2,6,10-trimethyl-11-(2-methyl-4-thiazolyl)-undec-10-en-1-al with and ethylketone carboxylic acid; macrolactonizing the acid; antitumor, anticancer, antiproliferative
01/03/2008US20080004469 Method and apparatus for producing polyhydroxy carboxylic acid
01/03/2008US20080004455 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
01/03/2008US20080003208 Creatine-ligand compounds and methods of use thereof
01/02/2008EP1873141A1 Calcium bis[2s)-3-[3-(2s)-3-(4-chloro-2-cyanophenoxy)-2- fluoropropoxy¨phenyl]-2-isopropoxypropionate] and intermediate thereof
01/02/2008EP1871735A1 Antioxidants
01/02/2008EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
01/02/2008CN101098846A Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
01/02/2008CN101098845A 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
01/01/2008US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1
12/2007
12/27/2007WO2007147880A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007WO2007147879A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007WO2007147256A1 Fatty acid hydroxylases and uses thereof
12/27/2007CA2657967A1 Cyclopentane derivatives as antiglaucoma agents
12/27/2007CA2655744A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655643A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007CA2655544A1 Fatty acid hydroxylases and uses thereof
12/26/2007CN101092348A Method for producing aluminum citrate from kaoline
12/26/2007CN101092347A Method for preparing levulinic acid from hexabasic sugar catalyzed and hydrolyzed by fire resistant and highly acidic resin
12/26/2007CN101092346A Method for preparing 10 ¿C hydroxy capric acid
12/26/2007CN101092342A Chemical process for the preparation of intermediates to obtain n-formyl hydroxy-lamine compounds
12/26/2007CN100357244C Aspirin-triggered lipid mediators
12/25/2007US7312246 Inhibiting interaction of alpha-helical protein with another protein or binding site; inhibiting cellular invasion of HIV
12/21/2007WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/20/2007US20070293577 topical cosmetics such as Hydroxycitric acid-2-palmitate sodium salt, possessing body firming and slimming effects
12/18/2007US7309698 Compositions for delivering bisphosphonates
12/13/2007WO2007142110A1 Novel carboxylic acid compound, use thereof, and process for producing the same
12/13/2007WO2007141295A1 Process for preparing phenoxy acetic acid derivatives
12/13/2007US20070287856 Process for producing perfluorodiacyl fluorinated compounds
12/13/2007DE102006026573A1 Stabile, hochkonzentrierte Aluminiumcarboxylat-Lösungen Stable, highly concentrated aluminum carboxylate solutions
12/12/2007EP1718602A4 Therapeutic and carrier molecules
12/12/2007CN101085730A Method for purifying malic acid
12/12/2007CN100354247C Calixarene kind lean uranium discharge prometor, its preparation method and use
12/11/2007CA2442288C A novel catalytic formulation and its preparation
12/06/2007WO2007140091A1 Coating composition
12/06/2007WO2007137410A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/06/2007WO2007107869A3 Lipid derivatives
12/06/2007CA2835964A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/06/2007CA2651724A1 Biomarkers for diagnosing multiple sclerosis, and methods thereof
12/05/2007EP1862444A2 Ether compounds, compositions, and uses thereof
12/05/2007EP1861352A1 Method for producing optically active 3-phenylpropionic acid derivatives and follow-on products of the latter
12/05/2007EP1861351A2 Novel triglycerides and method of preparation thereof
12/05/2007EP1638544B1 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
12/05/2007CN101084178A (benzyloxy-biphenyl) acetic acids and derivatives thereof
12/04/2007US7304093 Ketone compounds and compositions for cholesterol management and related uses
11/2007
11/29/2007WO2007135109A1 Metal complexes comprising a ligand derived from 2-aryl-2-hydroxyacetic acid and a divalent or trivalent metal cation, and their use
11/29/2007WO2002028345A3 Aldehyde-releasing compounds
11/29/2007US20070276138 Modulators of peroxisome proliferator activated receptors
11/29/2007US20070276045 Anti-Bacterial Compounds
11/29/2007CA2651598A1 Compounds for the treatment of metabolic disorders
11/28/2007EP1858834A1 Biologically degradable gas hydrate inhibitors
11/28/2007CN101080378A Process for purifying hydroxycarboxylic acid, process for producing cyclic ester, and process for producing polylhydroxycaboxylic acid
11/28/2007CN100351281C Process of making press molded materials using heat activated tertiary amine urethane catalysts
11/27/2007US7301052 Process for producing perfluorodiacyl fluorinated compounds
11/27/2007US7301050 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
11/27/2007US7300646 Skin lightening agents, compositions and methods
11/24/2007CA2590122A1 Tartrate salt of isofagomine and methods of use
11/22/2007WO2007115020A3 Therapeutic prostaglandin compounds for the treatment of glaucoma
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/21/2007CN101074190A Alpha-substituted 3,5-bisubsituted acrylic acid and its derivative, preparation and use
11/21/2007CN100349848C Method for converting sodium gulonate to gulonic acid in Vit C production
11/20/2007CA2260926C Illudin analogs useful as antitumor agents
11/15/2007WO2007131012A1 12-aryl or heteroaryl prostaglandin analogs
11/15/2007WO2007128918A1 Method for purification of an organic acid by chromatography
11/15/2007WO2007102105A3 Method for preparing an organic amine-lactic acid complex
11/15/2007US20070265464 7-[(1R,2S,3R,5R)-2-(3,5-Bis-trifluoromethyl-phenoxymethyl)-5-chloro-3-hydroxy-cyclopentyl]-heptanoic acid; glaucoma and/or ocular hypertension
11/15/2007US20070265459 Soy based polyols
11/15/2007US20070265323 Compounds for the treatment of metabolic disorders
11/15/2007US20070265322 Compounds for the treatment of metabolic disorders
11/15/2007CA2651022A1 12-aryl or heteroaryl prostaglandin analogs
11/15/2007CA2650952A1 Therapeutic compounds
11/14/2007EP1853544A2 Trans carotenoids, their synthesis, formulation and uses
11/14/2007EP1853538A2 Modulator
11/14/2007CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007CN100348569C Induction of apoptosis in cancer cells
11/13/2007US7294728 Lipoxin compounds and their use in treating cell proliferative disorders
11/08/2007WO2007126609A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
11/08/2007US20070259958 Prevention of Neutrophil Recruitment
11/08/2007US20070259890 Compounds and Compositions as Ppar Modulators
11/08/2007CA2647859A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
11/07/2007EP1513526B1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
11/07/2007CN101066915A Synthesis of 2,4-D
11/06/2007USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/01/2007WO2007124394A1 Substituted biphenyl carboxylic acids and derivatives thereof
11/01/2007WO2007124351A1 Terphenyl derivatives for treatment of alzheimer' s disease
11/01/2007WO2006093874A3 Novel triglycerides and method of preparation thereof
11/01/2007US20070254957 Triaryl compounds and derivates thereof
11/01/2007CA2650006A1 Substituted biphenyl carboxylic acids and derivatives thereof
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 147